本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Accendra Health Inc

1.16
0.0000
成交量:110.51萬
成交額:125.21萬
市值:8,920.95萬
市盈率:-0.29
高:1.18
開:1.14
低:1.09
收:1.16
52周最高:5.69
52周最低:0.9337
股本:7,690.47萬
流通股本:5,650.89萬
量比:0.42
換手率:1.96%
股息:- -
股息率:- -
每股收益(TTM):-3.9457
每股收益(LYR):-14.3179
淨資產收益率:-198.35%
總資產收益率:0.64%
市淨率:-0.16
市盈率(LYR):-0.08

資料載入中...

2020/09/01

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/09/01

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/09/01

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/22

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/14

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/14

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/26

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/26

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/26

財報披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/26

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/26

財報披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/05

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]